EarlySense Names New Senior Vice President of Strategic Partnerships

EarlySense, a global developer of contact-free, continuous monitoring solutions for the healthcare continuum, has appointed John Dragovits as senior vice president of Strategic Partnerships. Dragovits will manage EarlySense’s relationships with current and future business partners both domestically as well as in the international markets. These partnerships may include technology partners such is the case with Hillrom, healthcare organizations, technology developers and integrators, patient groups and more.
 
“Partner collaboration has played an important role in EarlySense’s growth and has been instrumental in helping us reach our goal of establishing contact-free continuous monitoring as a standard of care,” said Matt Johnson, EarlySense CEO. “We look forward to tapping into John’s expertise to strengthen current strategic partnerships and help bring in new relationships that will enable us to continue to elevate patient safety and care.”
 
Dragovits has more than 30 years of experience as a healthcare and healthcare IT executive leader. He previously served in vice presidential roles with electronic health records companies Cerner Corporation (Nasdaq: CERN) as well as senior vice president and general manager of Revenue Cycle at Allscripts. He was also held health system senior executive roles, having served as chief financial officer (CFO) and chief operating officer of Dallas’ Children’s Health and executive vice president and CFO of Parkland Health & Hospital System.

Dragovits is a former U.S. Navy officer as well as a CPA and holds graduate and undergraduate degrees from Rice University. 
 
“EarlySense is a recognized innovator within the patient monitoring markets, and has played an important role in advancing patient safety and outcomes in healthcare facilities worldwide,” said Dragovits. “I am honored to join the EarlySense team and to explore new avenues to bring contact-free continuous monitoring to even more patients, families and health teams.”

EarlySense’s contact-free continuous monitoring (CFCM) system tracks respiratory rate, heart rate and movement without ever touching the patient. The sensor, placed under the patient’s mattress, transmits real-time patient data for the early detection of clinical changes to a display outside of the patient’s room, limiting the need for staff to gown up and enter isolation areas. As a contact-free monitoring solution, there are no leads or other wearable devices to adjust or to touch the patient’s body.
 
EarlySense’s CFCM system is currently one of the strategic medical technologies being used by Israel’s Sheba Medical Center to help protect staff while monitoring isolated patients suspected of coronavirus exposure.
 
“We are doing our utmost to provide patients with quality care and comfort while minimizing the danger COVID-19 poses to our health practitioners and to the public,” said Dr. Eyal Zimlichman, chief medical officer and chief innovation officer at Sheba Medical Center. “We are grateful to EarlySense for answering an open call from our ARC innovation center for technologies and  providing its contact-free patient monitoring system. Together with additional protocols, we are well-prepared to care for our isolated COVID-19 patients.”